Our research team has experience and expertise in several niche areas including, Pituitary Neuro-endocrine research, MASLD (Metabolic Associated Steatotic Liver Disease), Diabetes Technology, Precision in Diabetes Health Care Adminustration, Genetic Epidemiology, Metabolic Bone Disease, Islet-cell Transplantation, Clamp studies and Computer modelling/ IVGTT.
The Endocrine Unit is involved in multiple investigator-initiated and industry-sponsored research projects. The unit has been running clinical trials with the Clinical Investigation Centre in UMMC for decades- landmark multi-national trials in the fields of diabetes and endocrinology that we have contributed to include ADVANCE, ATLANTUS, CANVAS, SOUL, FIGARO, FIDELIO, EXSCEL and PIONEER 6.
Our research output (listed in Publications section) has been publised in high impact journals, and presented locally and internationally. A selection of key journals that have published our work as as follows;
Our clinician-scientists are involved in research collaborations globally, including with Tsinghua University, Harvard University, the University of Oxford, National University of Singapore (NUS), Shanghai Jiao Tong University, Imperial College London, University of Leicester and the Chinese University of Hong Kong.
|
1
|
Age-dependent FRAX-based assessment and intervention thresholds for therapeutic decision making in osteoporosis in the Malaysian population |
|
2
|
Real-world evaluationof care of type 2 diabetes in Malaysia: A cross-sectional analysis of the treatment adherence to guideline evaluation in type 2 diabetes (TARGET-T2D) study |
|
1
|
CANVAS |
|
2
|
FIGARO |
|
3
|
ADVANCE |
|
4
|
FIDELIO |
|
5
|
SOUL |
|
6
|
PIONEER 6 |
|
1 |
Using big data to improve population health and resource allocation for people with diabetes In Malaysia, Co-Researcher, KPM(JPT), Medical Research Council, UK (MRC,UK) |
|
2 |
Prevalence and Predictors of RAI failure in patients Hyperthyroidism in UMMC |
|
3 |
Diabetic osteosarcopenia: Understanding the Relationship between Type 2 diabetes mellitus and musculoskeletal health. |
|
4 |
Difference of basal insulin titration method in reducing HbA1c among type 2 diabetes Mellitus (T2DM) patients. |
|
5 |
Real-World Burden of Comorbidity and Its Determinants in People with Type 2 Diabetes |
|
6 |
Plasma Adiponectin, Glycaemic Control And Insulin Use In Women With Gestational DiabetesMellitus: A Prospective, Observational Study |
|
7 |
Worldwide Phenotypes and Transitions in Obesity-Related Multimorbidity |
|
8 |
Treatment AdheRence to Guideline EvaluaTionin T2D (TARGET-T2D) Study |
|
9 |
Hypothalamic Pituitary Dysfunction After Spontaneous Subarachnoid Haemorrhage:A Prospective Longitudinal Cohort Study |
|
10 |
Opioid Endocrinopathy: Prevalence, Predictors and Outcomes |
|
11 |
The Role of Bone Mineral Density Added to Fracture Risk Assessment Tool (FRAX) in Therapeutic Decision-making For Osteoporosis In A Malaysian Population |
|
12 |
Real world evidence for the use of sglt2-inhibitors in patients with type 2 dm in a Malaysian Tertiary care centre |
|
13 |
DNLITE-IVD103: A Novel Biomarker To Predict Progression Of Diabetic Kidney Disease |
|
14 |
Value Of 30 and 60 Minute Cortisol Value During Short Synacthen Test– Can We Do Away With One Or The Other? |
|
15 |
Prednisolone As A Safe Option For Glucocorticoid Replacement In Patients With Adrenocorticotroph Deficiency During Ramadan Fasting: A Pilot Study |
|
16 |
The Prevalence and Predictive Factors of Weight Bias Amongst Medical Students in University of Malaya – A Cross-sectional Descriptive Study |
|
17 |
Prevalence and phenotypic variability of healthcare workers with overweight and obesity in University of Malaya Medical Centre |
Last Update: 06/11/2024